أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

orion corporation - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

orion corporation - methotrexate - tablet - 10 milligram(s) - other immunosuppressants; methotrexate

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

morningside healthcare ltd - methotrexate - tablet - 2.5 milligram(s) - other immunosuppressants; methotrexate

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

pfizer private limited - methotrexate - tablet - 2.500 mg - methotrexate 2.500 mg

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

orion corporation - methotrexate - tablet - 2.5 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

orion corporation - methotrexate - tablet - 10 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

a-s medication solutions - methotrexate sodium (unii: 3ig1e710zn) (methotrexate - unii:yl5fz2y5u1) - methotrexate 2.5 mg - neoplastic diseases methotrexate is indicated in the treatment of gestational choriocarcinoma, chorio-adenoma destruens and hydatidiform mole. methotrexate is used in maintenance therapy in combination with other chemotherapeutic agents. methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous t cell lymphoma), and lung cancer, particularly squamous cell and small cell types. methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non-hodgkin’s lymphomas. psoriasis methotrexate is indicated in the symptomatic control of severe, recalcitrant, disabling psoriasis that is not adequately responsive to other forms of therapy, but only when the diagnosis has been established, as by biopsy and/or after dermatologic consultation . it is important to ensure that a psoriasis “flare” is not due to an undiagnosed concomitant disease affec

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - methotrexate - oral tablet - 2.5mg

المملكة المتحدة - الإنجليزية - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandoz ltd - methotrexate - oral tablet - 2.5mg